HealthDay - System designed to work with magnetic resonance imaging devices
The first heart pacemaker designed to be used safely during certain MRI exams has been approved by the U.S. Food and Drug Administration.
Up to now, patients with pacemakers have been advised not to have an MRI, which has the potential to interfere with a pacemaker's settings and may cause the wiring to overheat, the FDA said in a news release.
The Revo MRI SureScan Pacing System has a built-in function that's meant to be turned on before a person undergoes an MRI. Even with the newly approved device, however, an MRI can only be used on certain people, on certain parts of the body, and under the supervision of specially trained technicians, the agency said.
Of 211 people implanted with the device who had an MRI during clinical testing, none had MRI-related complications, the FDA said.
The Revo device is produced by Medtronic Inc., based in Mounds View, Minn.
Copyright © 2011 HealthDay. All rights reserved.
ACR Collaborative Model Achieves 20 Percent Improvement in PI-QUAL Scores for Prostate MRI
May 9th 2024Using a learning network model to discuss challenges and share insights among radiology departments from five different organizations, researchers noted that 87 percent of audited prostate MRI exams had PI-QUAL scores > 4 at the conclusion of the collaborative program.
Breast MRI and Dense Breasts: A Closer Look at Early Findings from a New Prospective Trial
May 2nd 2024Supplemental breast MRI had a cancer detection rate (CDR) of 20/1000 and a positive predictive value (PPV) of 50 percent, according to preliminary findings from a prospective trial involving women with heterogeneously or very dense breasts.